The bacterial toxin produced by E. coli, the main suspect in the increase in intestinal cancer among those under 50 | Bowel cancer

Exposure to a bacterial toxin early in life has become a leading suspect in the rise in bowel cancer among under-50s, MPs have heard.

Cases of early-onset bowel cancer have doubled in many countries over the past two decades, and if increasing obesity and falling physical activity are contributing, researchers say other factors must also be involved.

Dr Karl Smith-Byrne, a senior molecular epidemiologist at the University of Oxford, told the Commons Science and Technology Committee that known risk factors for colorectal cancer, such as obesity, smoking and alcohol, can only explain about half of cases diagnosed by doctors.

He said he did not find it “plausible” that the increase in early-onset bowel cancer could be entirely explained by risk factors that researchers were already aware of.

Last year, scientists identified a toxin called colibactin, produced by certain variants of E coli bacteria in the intestine, as a potential factor in the early onset of colorectal cancer. The characteristic mutations caused by the toxin were three times more common in tumors from people younger than 40 than in those from people older than 70.

More work is needed to understand whether colibactin actually causes bowel cancer, but it’s a question that scientists are currently actively investigating. “That’s probably the main explanation at the moment,” Smith-Byrne told MPs.

Professor Mike Stratton of the Sanger Institute, who was not at the hearing, said colibactin causes mutations in some children but not others, with evidence of mutations appearing as early as early childhood. By the age of 10, affected children may have a “mutational burden” similar to that of a 50-year-old, his work showed.

“If it causes mutations, it causes mutations at a sensitive time earlier in life, and that can give that person’s colon or rectum a head start in their journey toward cancer or developing these tumors,” said Smith-Byrne, who is himself a survivor of early rectal cancer.

Some suspect that particular variants of E coli which normally live harmlessly in the intestine have evolved over recent decades to produce colibactin. Professor Elio Riboli, a cancer epidemiologist at Imperial College London, told the committee: “This colibactin is found mainly in people born after 1960. Something happened in the E coli bacteria… There must have been a mutation, and there is a new bacteria.

Bowel cancer is the third most common cancer worldwide, accounting for approximately one in ten cases. The disease is still much more common among those over 50, but global figures suggest that diagnoses are rising sharply among younger people.

Professor Helen Coleman, a cancer epidemiologist at Queen’s University Belfast, told MPs that colibactin was “the first new clue we’ve had in a while” but that its potential role in bowel cancer was still being studied.

“Even if we’re talking about adults who are diagnosed with cancer between the ages of 18 and 49, it’s highly likely that these are very early exposures,” she said. “It might be something you were exposed to from early childhood, maybe even prenatally, and it makes studying very difficult.”

Riboli said that even if scientists were to discover the unknown factors behind different cancers, people should minimize the already obvious risks. In the UK and US, alcohol consumption and smoking are both falling, but obesity is increasing and physical activity is declining. “Quick victory could come from applying what we know,” he said. “We could prevent around 60% of the cancers that currently occur, but we are not applying what we know in society. »

Gn Health

Logo